Role of cancer stem cells in brain tumors

BioMedicine (Netherlands)

Volumn 2, Issue 3, 2012, Pages 84-91

  Chen, Ya Huey ^a,b   Hung, Mien Chie ^a,b,c,d   Shyu, Woei Cherng ^a,b  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c ASIA UNIVERSITY   (Taiwan)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Brain cancer stem cells; CD133; Glioblastoma; Medulloblastomas; Perivascular niche; Targeting therapies

Indexed keywords

BMI1 PROTEIN; BONE MORPHOGENETIC PROTEIN; CD133 ANTIGEN; CELL MARKER; GROWTH FACTOR; HYPOXIA INDUCIBLE FACTOR; MICRORNA; MICRORNA 124; MICRORNA 137; NOTCH RECEPTOR; PROTEIN TYROSINE KINASE; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR EZH2; TUMOR MARKER; UNCLASSIFIED DRUG; VASCULOTROPIN;

APOPTOSIS; BRAIN CANCER; BRAIN TUMOR; CANCER STEM CELL; CELL FATE; CELL PROLIFERATION; CELL RENEWAL; CELL SURVIVAL; CELL VIABILITY; EPIGENETICS; GENE EXPRESSION REGULATION; GLIOBLASTOMA; HUMAN; MEDULLOBLASTOMA; NONHUMAN; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION;

EID: 84866489660     PISSN: 22118020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomed.2012.06.001     Document Type: Review

References (82)

1. Stupp R., Hegi M.E., Mason W.P., van den Bent M.J., Taphoorn M.J., Janzer R.C., et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 2009, 10:459-466.
2. Hjelmeland A.B., Lathia J.D., Sathornsumetee S., Rich J.N. Twisted tango: brain tumor neurovascular interactions. Nat Neurosci 2011, 14:1375-1381.
3. Charles N.A., Holland E.C., Gilbertson R., Glass R., Kettenmann H. The brain tumor microenvironment. Glia 2011, 59:1169-1180.
4. Dirks P.B. Brain tumor stem cells: the cancer stem cell hypothesis writ large. Mol Oncol 2010, 4:420-430.
5. Singh S.K., Hawkins C., Clarke I.D., Squire J.A., Bayani J., Hide T., et al. Identification of human brain tumour initiating cells. Nature 2004, 432:396-401.
6. Bao S., Wu Q., Sathornsumetee S., Hao Y., Li Z., Hjelmeland A.B., et al. Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor. Cancer Res 2006, 66:7843-7848.
7. Bao S., Wu Q., McLendon R.E., Hao Y., Shi Q., Hjelmeland A.B., et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006, 444:756-760.
8. Gilbertson R.J., Rich J.N. Making a tumour's bed: glioblastoma stem cells and the vascular niche. Nat Rev Cancer 2007, 7:733-736.
9. Calabrese C., Poppleton H., Kocak M., Hogg T.L., Fuller C., Hamner B., et al. A perivascular niche for brain tumor stem cells. Cancer Cell 2007, 11:69-82.
10. Li Z., Bao S., Wu Q., Wang H., Eyler C., Sathornsumetee S., et al. Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells. Cancer Cell 2009, 15:501-513.
11. Folkins C., Shaked Y., Man S., Tang T., Lee C.R., Zhu Z., et al. Glioma tumor stem-like cells promote tumor angiogenesis and vasculogenesis via vascular endothelial growth factor and stromal-derived factor 1. Cancer Res 2009, 69:7243-7251.
12. Salmaggi A., Boiardi A., Gelati M., Russo A., Calatozzolo C., Ciusani E., et al. Glioblastoma-derived tumorospheres identify a population of tumor stem-like cells with angiogenic potential and enhanced multidrug resistance phenotype. Glia 2006, 54:850-860.
13. Liu G., Yuan X., Zeng Z., Tunici P., Ng H., Abdulkadir I.R., et al. Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma. Mol Cancer 2006, 5:67.
14. Behin A., Hoang-Xuan K., Carpentier A.F., Delattre J.Y. Primary brain tumours in adults. Lancet 2003, 361:323-331.
15. Stupp R., Mason W.P., van den Bent M.J., Weller M., Fisher B., Taphoorn M.J., et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. New Engl J Med 2005, 352:987-996.
16. Holland E.C. Glioblastoma multiforme: the terminator. Proc Natl Acad Sci U S A 2000, 97:6242-6244.
17. Hemmati H.D., Nakano I., Lazareff J.A., Masterman-Smith M., Geschwind D.H., Bronner-Fraser M., et al. Cancerous stem cells can arise from pediatric brain tumors. Proc Natl Acad Sci U S A 2003, 100:15178-15183.
18. Ellison D. Classifying the medulloblastoma: insights from morphology and molecular genetics. Neuropathol Appl Neurobiol 2002, 28:257-282.
19. Lapidot T., Sirard C., Vormoor J., Murdoch B., Hoang T., Caceres-Cortes J. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 1994, 367:645-648.
20. Bonnet D., Dick J.E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 1997, 3:730-737.
21. Ignatova T.N., Kukekov V.G., Laywell E.D., Suslov O.N., Vrionis F.D., Steindler D.A. Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro. Glia 2002, 39:193-206.
22. Yuan X., Curtin J., Xiong Y., Liu G., Waschsmann-Hogiu S., Farkas D.L., et al. Isolation of cancer stem cells from adult glioblastoma multiforme. Oncogene 2004, 23:9392-9400.
23. Galli R., Binda E., Orfanelli U., Cipelletti B., Gritti A., De Vitis S., et al. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res 2004, 64:7011-7021.
24. Jordan C.T., Guzman M.L., Noble M. Cancer stem cells. N Engl J Med 2006, 355:1253-1261.
25. Singh S.K., Clarke I.D., Terasaki M., Bonn V.E., Hawkins C., Squire J., et al. Identification of a cancer stem cell in human brain tumors. Cancer Res 2003, 63:5821-5828.
26. Seaberg R.M., van der Kooy D. Stem and progenitor cells: the premature desertion of rigorous definitions. Trend Neurosci 2003, 26:125-131.
27. Beier D., Hau P., Proescholdt M., Lohmeier A., Wischhusen J., Oefner P.J., et al. CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Res 2007, 67:4010-4015.
28. Clement V., Dutoit V., Marino D., Dietrich P.Y., Radovanovic I. Limits of CD133 as a marker of glioma self-renewing cells. Int J Cancer 2009, 125:244-248.
29. Ogden A.T., Waziri A.E., Lochhead R.A., Fusco D., Lopez K., Ellis J.A., et al. Identification of A2B5+CD133- tumor-initiating cells in adult human gliomas. Neurosurgery 2008, 62:505-515.
30. Son M.J., Woolard K., Nam D.H., Lee J., Fine H.A. SSEA-1 is an enrichment marker for tumor-initiating cells in human glioblastoma. Cell Stem Cell 2009, 4:440-452.
31. Bao S., Wu Q., Li Z., Sathornsumetee S., Wang H., McLendon R.E., et al. Targeting cancer stem cells through L1CAM suppresses glioma growth. Cancer Res 2008, 68:6043-6048.
32. Rasper M., Schafer A., Piontek G., Teufel J., Brockhoff G., Ringel F., et al. Aldehyde dehydrogenase 1 positive glioblastoma cells show brain tumor stem cell capacity. Neuro Oncol 2010, 12:1024-1033.
33. Lathia J.D., Gallagher J., Heddleston J.M., Wang J., Eyler C.E., Macswords J., et al. Integrin alpha 6 regulates glioblastoma stem cells. Cell Stem Cell 2010, 6:421-432.
34. Anido J., Saez-Borderias A., Gonzalez-Junca A., Rodon L., Folch G., Carmona M.A., et al. TGF-beta receptor inhibitors target the CD44(high)/Id1(high) glioma-initiating cell population in human glioblastoma. Cancer Cell 2010, 18:655-668.
35. Mazzoleni S., Politi L.S., Pala M., Cominelli M., Franzin A., Sergi Sergi L., et al. Epidermal growth factor receptor expression identifies functionally and molecularly distinct tumor-initiating cells in human glioblastoma multiforme and is required for gliomagenesis. Cancer Res 2010, 70:7500-7513.
36. Clement V., Marino D., Cudalbu C., Hamou M.F., Mlynarik V., de Tribolet N., et al. Marker-independent identification of glioma-initiating cells. Nat Methods 2010, 7:224-228.
37. Alexander C.M., Puchalski J., Klos K.S., Badders N., Ailles L., Kim C.F., et al. Separating stem cells by flow cytometry: reducing variability for solid tissues. Cell Stem Cell 2009, 5:579-583.
38. Shen Q., Wang Y., Kokovay E., Lin G., Chuang S.M., Goderie S.K., et al. Adult SVZ stem cells lie in a vascular niche: a quantitative analysis of niche cell-cell interactions. Cell Stem Cell 2008, 3:289-300.
39. Tavazoie M., Van der Veken L., Silva-Vargas V., Louissaint M., Colonna L., Zaidi B., et al. A specialized vascular niche for adult neural stem cells. Cell Stem Cell 2008, 3:279-288.
40. Hovinga K.E., Shimizu F., Wang R., Panagiotakos G., Van Der Heijden M., Moayedpardazi H., et al. Inhibition of notch signaling in glioblastoma targets cancer stem cells via an endothelial cell intermediate. Stem Cells 2010, 28:1019-1029.
41. Lathia J.D., Rao M.S., Mattson M.P., Ffrench-Constant C. The microenvironment of the embryonic neural stem cell: lessons from adult niches?. Dev Dyn 2007, 236:3267-3282.
42. Ljubimova J.Y., Fugita M., Khazenzon N.M., Das A., Pikul B.B., Newman D., et al. Association between laminin-8 and glial tumor grade, recurrence, and patient survival. Cancer 2004, 101:604-612.
43. Kawataki T., Yamane T., Naganuma H., Rousselle P., Anduren I., Tryggvason K., et al. Laminin isoforms and their integrin receptors in glioma cell migration and invasiveness: evidence for a role of alpha5-laminin(s) and alpha3beta1 integrin. Exp Cell Res 2007, 313:3819-3831.
44. Zheng P.P., Hop W.C., Luider T.M., Sillevis Smitt P.A., Kros J.M. Increased levels of circulating endothelial progenitor cells and circulating endothelial nitric oxide synthase in patients with gliomas. Ann Neurol 2007, 62:40-48.
45. Charles N., Ozawa T., Squatrito M., Bleau A.M., Brennan C.W., Hambardzumyan D., et al. Perivascular nitric oxide activates notch signaling and promotes stem-like character in PDGF-induced glioma cells. Cell Stem Cell 2010, 6:141-152.
46. Eyler C.E., Wu Q., Yan K., MacSwords J.M., Chandler-Militello D., Misuraca K.L., et al. Glioma stem cell proliferation and tumor growth are promoted by nitric oxide synthase-2. Cell 2011, 146:53-66.
47. Solecki D.J., Liu X.L., Tomoda T., Fang Y., Hatten M.E. Activated Notch2 signaling inhibits differentiation of cerebellar granule neuron precursors by maintaining proliferation. Neuron 2001, 31:557-568.
48. Gaiano N., Fishell G. The role of notch in promoting glial and neural stem cell fates. Annu Rev Neurosci 2002, 25:471-490.
49. Purow B.W., Haque R.M., Noel M.W., Su Q., Burdick M.J., Lee J., et al. Expression of Notch-1 and its ligands, Delta-like-1 and Jagged-1, is critical for glioma cell survival and proliferation. Cancer Res 2005, 65:2353-2363.
50. Fan X., Mikolaenko I., Elhassan I., Ni X., Wang Y., Ball D., et al. Notch1 and notch2 have opposite effects on embryonal brain tumor growth. Cancer Res 2004, 64:7787-7793.
51. Fan X., Matsui W., Khaki L., Stearns D., Chun J., Li Y.M., et al. Notch pathway inhibition depletes stem-like cells and blocks engraftment in embryonal brain tumors. Cancer Res 2006, 66:7445-7452.
52. Shih A.H., Holland E.C. Notch signaling enhances nestin expression in gliomas. Neoplasia 2006, 8:1072-1082.
53. Zhang X.P., Zheng G., Zou L., Liu H.L., Hou L.H., Zhou P., et al. Notch activation promotes cell proliferation and the formation of neural stem cell-like colonies in human glioma cells. Mol Cell Biochem 2008, 307:101-108.
54. Park Y., Rangel C., Reynolds M.M., Caldwell M.C., Johns M., Nayak M., et al. Drosophila perlecan modulates FGF and hedgehog signals to activate neural stem cell division. Dev Biol 2003, 25:247-257.
55. Becher O.J., Hambardzumyan D., Fomchenko E.I., Momota H., Mainwaring L., Bleau A.M., et al. Gli activity correlates with tumor grade in platelet-derived growth factor-induced gliomas. Cancer Res 2008, 68:2241-2249.
56. Dahmane N., Sanchez P., Gitton Y., Palma V., Sun T., Beyna M., et al. The Sonic Hedgehog-Gli pathway regulates dorsal brain growth and tumorigenesis. Development 2001, 128:5201-5212.
57. Clement V., Sanchez P., de Tribolet N., Radovanovic I., Ruiz i Altaba A. HEDGEHOG-GLI1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity. Curr Biol: CB 2007, 17:165-172.
58. Bar E.E., Chaudhry A., Lin A., Fan X., Schreck K., Matsui W., et al. Cyclopamine-mediated hedgehog pathway inhibition depletes stem-like cancer cells in glioblastoma. Stem Cells 2007, 25:2524-2533.
59. Bachoo R.M., Maher E.A., Ligon K.L., Sharpless N.E., Chan S.S., You M.J., et al. Epidermal growth factor receptor and Ink4a/Arf: convergent mechanisms governing terminal differentiation and transformation along the neural stem cell to astrocyte axis. Cancer Cell 2002, 1:269-277.
60. Alcantara Llaguno S., Chen J., Kwon C.H., Jackson E.L., Li Y., Burns D.K., et al. Malignant astrocytomas originate from neural stem/progenitor cells in a somatic tumor suppressor mouse model. Cancer Cell 2009, 15:45-56.
61. Soeda A., Inagaki A., Oka N., Ikegame Y., Aoki H., Yoshimura S., et al. Epidermal growth factor plays a crucial role in mitogenic regulation of human brain tumor stem cells. J Biol Chem 2008, 283:10958-10966.
62. Eyler C.E., Foo W.C., LaFiura K.M., McLendon R.E., Hjelmeland A.B., Rich J.N. Brain cancer stem cells display preferential sensitivity to Akt inhibition. Stem Cells 2008, 26:3027-3036.
63. Reddi A.H. Bone morphogenetic proteins: an unconventional approach to isolation of first mammalian morphogens. Cytokine Growth Factor Rev 1997, 8:11-20.
64. Panchision D.M., McKay R.D. The control of neural stem cells by morphogenic signals. Curr Opin Genet Dev 2002, 12:478-487.
65. Piccirillo S.G., Reynolds B.A., Zanetti N., Lamorte G., Binda E., Broggi G., et al. Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells. Nature 2006, 444:761-765.
66. Lee J., Son M.J., Woolard K., Donin N.M., Li A., Cheng C.H., et al. Epigenetic-mediated dysfunction of the bone morphogenetic protein pathway inhibits differentiation of glioblastoma-initiating cells. Cancer Cell 2008, 13:69-80.
67. Dirks P. Bmi1 and cell of origin determinants of brain tumor phenotype. Cancer Cell 2007, 12:295-297.
68. Bruggeman S.W., Hulsman D., Tanger E., Buckle T., Blom M., Zevenhoven J., et al. Bmi1 controls tumor development in an Ink4a/Arf-independent manner in a mouse model for glioma. Cancer Cell 2007, 12:328-341.
69. Liggett W.H., Sidransky D. Role of the p16 tumor suppressor gene in cancer. J Clin Oncol 1998, 16:1197-1206.
70. Uhrbom L., Kastemar M., Johansson F.K., Westermark B., Holland E.C. Cell type-specific tumor suppression by Ink4a and Arf in Kras-induced mouse gliomagenesis. Cancer Res 2005, 65:2065-2069.
71. Suva M.L., Riggi N., Janiszewska M., Radovanovic I., Provero P., Stehle J.C., et al. EZH2 is essential for glioblastoma cancer stem cell maintenance. Cancer Res 2009, 69:9211-9218.
72. Orzan F., Pellegatta S., Poliani P.L., Pisati F., Caldera V., Menghi F., et al. Finocchiaro G: enhancer of Zeste 2 (EZH2) is up-regulated in malignant gliomas and in glioma stem-like cells. Neuropathol Appl Neurobiol 2011, 37:381-394.
73. Chan J.A., Krichevsky A.M., Kosik K.S. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 2005, 65:6029-6033.
74. Ernst A., Campos B., Meier J., Devens F., Liesenberg F., Wolter M., et al. De-repression of CTGF via the miR-17-92 cluster upon differentiation of human glioblastoma spheroid cultures. Oncogene 2010, 29:3411-3422.
75. Silber J., Lim D.A., Petritsch C., Persson A.I., Maunakea A.K., Yu M., et al. miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. BMC Med 2008, 6:14.
76. Gal H., Pandi G., Kanner A.A., Ram Z., Lithwick-Yanai G., Amariglio N., et al. MIR-451 and imatinib mesylate inhibit tumor growth of glioblastoma stem cells. Biochem Biophys Res Commun 2008, 376:86-90.
77. Knizetova P., Ehrmann J., Hlobilkova A., Vancova I., Kalita O., Kolar Z., et al. Autocrine regulation of glioblastoma cell cycle progression, viability and radioresistance through the VEGF-VEGFR2 (KDR) interplay. Cell Cycle 2008, 7:2553-2561.
78. Heddleston J.M., Li Z., McLendon R.E., Hjelmeland A.B., Rich J.N. The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype. Cell Cycle 2009, 8:3274-3284.
79. Seidel S., Garvalov B.K., Wirta V., von Stechow L., Schanzer A., Meletis K., et al. A hypoxic niche regulates glioblastoma stem cells through hypoxia inducible factor 2 alpha. Brain 2010, 133(Pt 4):983-995.
80. Bar E.E., Lin A., Mahairaki V., Matsui W., Eberhart C.G. Hypoxia increases the expression of stem-cell markers and promotes clonogenicity in glioblastoma neurospheres. Am J Pathol 2010, 177:1491-1502.
81. Tamura K., Aoyagi M., Wakimoto H., Ando N., Nariai T., Yamamoto M., et al. Accumulation of CD133-positive glioma cells after high-dose irradiation by gamma knife surgery plus external beam radiation. J Neurosurg 2010, 113:310-318.
82. Binello E., Germano I.M. Targeting glioma stem cells: a novel framework for brain tumors. Cancer Sci 2011, 102:1958-1966.